Steve O'Loughlin
2022
In 2022, Steve O'Loughlin earned a total compensation of $1.5M as Chief Financial Officer at Actinium Pharmaceuticals, a 53% increase compared to previous year.
Compensation breakdown
| Bonus | $185,000 |
|---|---|
| Option Awards | $891,144 |
| Salary | $400,000 |
| Total | $1,476,144 |
O'Loughlin received $891.1K in option awards, accounting for 60% of the total pay in 2022.
O'Loughlin also received $185K in bonus and $400K in salary.
Rankings
In 2022, Steve O'Loughlin's compensation ranked 2,258th out of 5,760 executives tracked by ExecPay. In other words, O'Loughlin earned more than 60.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,258 out of 5,760 | 61st |
Division Manufacturing | 1,224 out of 3,136 | 61st |
Major group Chemicals And Allied Products | 540 out of 1,422 | 62nd |
Industry group Drugs | 495 out of 1,323 | 63rd |
Industry Pharmaceutical Preparations | 360 out of 969 | 63rd |
Source: SEC filing on November 9, 2023.
O'Loughlin's colleagues
We found one more compensation record of an executive who worked with Steve O'Loughlin at Actinium Pharmaceuticals in 2022.
2022
Sandesh Seth
Actinium Pharmaceuticals
Chief Executive Officer
News
Actinium Pharmaceuticals CEO Sandesh Seth's 2023 pay rises 17% to $4.7M
November 5, 2024
Actinium Pharmaceuticals CEO Sandesh Seth's 2022 pay jumps 72% to $4M
November 9, 2023
Actinium Pharmaceuticals CEO Sandesh Seth's 2021 pay jumps 27% to $2.3M
November 21, 2022
Actinium Pharmaceuticals CEO Sandesh Seth's 2019 pay slips 20% to $1.1M
October 7, 2020